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Epidermal growth factor (EGF) binds to the extra- 
cellular domain of a specific 170,000-dalton trans- 
membrane glycoprotein; this  results  in rapid removal 
of both ligand and receptor from the cell surface. In 
WB cells, a rat hepatic epithelial cell  line, ligand-di- 
rected receptor internalization leads to receptor deg- 
radation. We tested whether the EGF receptor was 
replenished at a constitutive or enhanced rate follow- 
ing EGF binding  by immunoprecipitating biosyntheti- 
cally labeled EGF receptor from cells cultured with 
[35S]methionine. EGF stimulated receptor synthesis 
within 2 h in a dose-dependent manner; this  was par- 
ticularly evident  when examining the nascent form of 
the receptor. To determine the site of EGF action, total 
WB cell RNA was transferred to nitrocellulose paper 
after electrophoresis and was hybridized to cDNA 
probes from both the  external and cytoplasmic coding 
regions of the human EGF receptor. EGF increased 
receptor mRNA by 3-5-fold. Therefore, at least in 
some cells, the surface action of EGF that leads to EGF 
receptor degradation is counterbalanced by a positive 
effect on receptor synthesis. 
The cell surface complement of hormone and growth factor 
receptors is determined by their  rates of synthesis  and deg- 
radation  as well as by a regulated flux of receptors between 
surface and intracellular  compartments. Ligand binding rap- 
idly accelerates ligand and receptor internalization, a process 
referred to as “down regulation” (1, 2). Experiments using 
radiolabeled EGF’ have demonstrated that down regulation 
drastically reduces cell surface EGF binding capacity and 
Ieads, in most instances, to ligand degradation (1-5). Down 
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regulation may also lead to EGF receptor degradation (6). 
Initial  studies of EGF receptor synthesis using anti-receptor 
antibodies have shown that receptor protein is cotranslation- 
alIy  glycosylated so that  the nascent receptor migrates at  an 
estimated M, of  160,000. Within 15-45 min it matures to  the 
170,000-dalton form and eventually assumes its position in 
the plasma membrane (7-11). 
During our investigations of EGF receptor metabolism dur- 
ing rat liver regeneration (12, 13) we raised an antiserum to 
the  rat EGF receptor. In  the present study we have used this 
antiserum to investigate receptor synthesis in a continuous 
line of nontransformed rat liver epithelial cells (WB). These 
cells were initially isolated from a primary culture of Fisher 
344 rat hepatocytes (14). WB cells respond to EGF with 
enhanced DNA synthesis and alteration of the activity of 
several glycolytic enzymes (15). EGF activates the WB cell 
EGF receptor tyrosine-specific protein kinase both in vitro 
(15) and in uiuo.’ As expected, the addition of EGF to WB 
cells led to receptor internalization  and degradation. However, 
when the rates of EGF receptor protein  and mRNA synthesis 
were examined after  EGF stimulation, an unexpected result 
was obtained; EGF increased EGF receptor synthesis. 
EXPERIMENTAL PROCEDURES 
Cell Culture and Immunoprecipitation-WB cells were grown to 
confluence at 37 “C in a 95% air, 5% CO, atmosphere on 35-mm 
Corningplastic tissue culture dishes with Richter’s improved minimal 
essential medium (Irvine Scientific) plus 0.1 pM insulin (Irvine Sci- 
entific) and 10% fetal bovine serum. To label WB cell proteins, the 
medium was changed to minimal essential medium supplemented 
with glutamine and containing only 2% of the normal methionine 
concentration and 50 pCi of [35S]methionine (New England Nuclear). 
At the indicated times, EGF purified from mouse salivary glands (16) 
was added to the cultures  either before, during, or after the labeling 
period. 
Prior to immunoprecipitation the cells were  washed with normal 
saline, and 0.5 ml  of lysis buffer was added to  the plates. Lysis buffer 
contained 1% Nonidet P-40, 50 mM Tris-HC1, pH 8.5, 0.15 M NaCI, 
5 mM EDTA, 0.1% bovine serum albumin, 10 pg/ml leupeptin, 25 
mM benzamidine, and 50 Fg/ml phenylmethylsulfonyl fluoride. Cells 
were scraped, the plates were washed with another 0.5 ml of lysis 
buffer, and  the lysates were transferred to microfuge tubes where  50 
pl  of 5 M NaCl was added. The samples were sonicated and  the residue 
was pelleted for 5 min in an Eppendorf microfuge. The supernatants 
were transferred to new microfuge tubes  and incubated for 10 min at 
21 “C with 20 p1 of a 1:l slurry of Pansorbin (Calbiochem)/lysis buffer 
and 5 pl of normal rabbit serum. After pelleting the Pansorbin, the 
supernatants were again transferred and tumbled with a  saturating 
amount (5 ell) of the polyclonal antiserum, 799, or normal rabbit 
serum for 30 min at 21 “C. The rabbit polyclonal antiserum was raised 
against native rat liver EGF receptor purified by EGF affinity chro- 
matography (17). Pansorbin/lysis buffer (20 ~1 of a 1:1 slurry) was 
added for an additional 45 min. Immunoprecipitates were pelleted in 
the microfuge and washed sequentially with 1 ml of the following 
buffers: 1) 50 mM Tris-HC1, pH 8.5, 0.5 M NaCI, 1 mM EDTA, 0.5% 
Nonidet P-40; 2)  50 mM Tris-HC1, pH 8.5,0.15 M NaCI, 1 mM EDTA, 
0.5% Nonidet P-40; and 3) 10 mM Tris-HC1, pH 8.5, 0.1% Nonidet 
P-40. The immunoprecipitates were  boiled for 5 min after the addition 
of 60 pl of sodium dodecyl sulfate containing sample buffer with 50 
mM 8-mercaptoethanol and then pelleted. Supernatants were sub- 
jected to 6 or 8% polyacrylamide gel electrophoresis. Gels  were 
stained, destained, and treated for 1 h with 1 M sodium salicylate. 
After drying, gels  were exposed (Kodak XAR film) for 1-3 days using 
a Kronex Intensifier. In some cases, the p170 band was identified and 
* W. R. Rackoff and H. S. Earp, unpublished results. 
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cut from dried gels. The gel pieces  were treated for 24 h a t  37 "C  with 
2 ml of 30% HZ02, 1% NH,OH. The  extract was analyzed by liquid 
scintillation  counting  using 5 ml of Scintiverse I1 and 5 ml of H20. 
RNA Preparation  and Hybridization-RNA was prepared by the 
method of Chirgwin et al. (18) from WB cells gr-own as indicated 
above. Cells from 8 confluent 100-mm tissue culture dishes were 
scraped directly into 4 M guanidinium isothiocyanate (1 ml/plate) 
and  the  plates were  washed  with 1 ml of the  same buffer. The 16-ml 
sample was homogenized with a  polytron apparatus for 10 s (set  7) 
and centrifuged  before initial  precipitation with acetic acid and 
ethanol.  The  precipitates were  resuspended and  reprecipitated twice 
in guanidine hydrochloride  before water  extraction  and  final  ethanol 
precipitation.  The  ratio of 260/280 absorbance was 1.95-2.00. Total 
RNA (40 pg) was  electrophoresed in 1% agarose, 2.2 M formaldehyde 
(19). X Hind111 digests were also electrophoresed on  the  same gel. The 
RNA was transferred to nitrocellulose and the filter was vacuum- 
dried a t  80 "C. After prehybridization  overnight, hybridization was 
performed  with the indicated probes  in 50% formamide at 42 "C for 
24 h (20).  Two cDNA probes cloned by Ullrich et al. (21) were  used, 
64-1  (an 1838-base pair  sequence  from  the coding region of the  human 
EGF receptor external  domain)  and  64-3  (a 768-base pair sequence 
from the cytoplasmic domain  in pUC12) Insert 64-1,  cDNA 64-3  in 
plasmid pUC12, and XHindIII digests were nick-translated usiflg a 
kit from Worthington and 75 pCi of [32P]dATP. The blots were 
washed with  4 changes of 2 X SSC  at  42 "C and 2 changes of 0.2 X 
SSC, 0.1% sodium dodecyl sulfate a t  55 "C. They were air-dried  and 
exposed using Kodak XAR film and  Dupont  Kronex  Intensifier for  2 
days. Densitometry was  performed using a Kontes  densitometer  and 
an  Hewlett-Packard  Integrator. 
RESULTS AND DISCUSSION 
WB cell proteins were labeled for 18 h  with ['"S]methionine. 
Labeling was stopped by changing  the medium and  EGF was 
then added to  the cells. A t  37 "C, EGF  treatment resulted in 
a time-dependent loss of prelabeled  immunoprecipitable p170. 
(Fig. 1). We then tested whether EGF influenced nascent 
receptor synthesis at the  same  time  it was directing degrada- 
EGF (100ng/ml) - + + + 
TIME (rnin) 120 120 60 30 
tion of pre-existing surface receptors. Confluent WB cells 
were labeled for 4 h with [3sS]methionine, with or without 
added EGF. EGF increased ["S]methionine incorporation 
into immunoprecipitated receptor in the 160,000-170,000- 
dalton region of the gel (p16O-pl70) (Fig. 2, lunes 3-6). Lane 
1 shows that  little  or  no 3sS-labeled p160-p170 was precipi- 
tated by normal  rabbit serum. 
Antiserum 199 specifically immunoprecipitates  either phos- 
phorylated or metabolically labeled EGF receptor from rodent 
and  human cells. This  antiserum also precipitates [3sS]me- 
thionine-labeled 135,000 dalton  EGF receptor protein (p135) 
from tunicamycin-treated  WB cells and  rat hepatocytes. 
Thus,  the  antiserum  contains  at  least some anti-protein de- 
terminants  that will detect  nascent nonglycosylated forms of 
the receptor. The lower molecular weight form (p160) has 
been demonstrated  to be cotranslationally glycosylated recep- 
tor  protein (7-11). In  WB cells, a shorter labeling  period (1 
h) clearly distinguished the 160- and 170-kDa forms and 
revealed that 10 ng/ml EGF increased 160-kDa synthesis 
within 2 h (Fig. 3 and  Table I). The effect of EGF  on receptor 
protein  synthesis was also observed in  the absence of glyco- 
sylation, i.e. EGF increased p135 synthesis  in  WB cells pre- 
treated for 30 min  with 10 pg/ml  tumicamycin (not shown). 
Since EGF alters amino acid transport (see Ref. l ) ,  we 
quantitated the increase in immunoprecipitable "S-labeled 
p170 and compared it to the increase in [:"SS]methionine 
incorporation into  total cellular protein  (Table I). Trichloro- 
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FIG. 1. EGF treatment leads to EGF receptor degradation 
in WB cells. Cells were labeled  with [%]methionine for 18 h. The 
cells  were changed to medium containing unlabeled methionine  and 
EGF at the indicated concentration. Immunoprecipitation, as de- 
scribed under  "Experimental Procedures" was performed a t  30, 60, 
and 120  min after  EGF  addition  and was followed by electrophoresis 
and fluorography. 
.+. 
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Anliserum t n r N " 7 9 9 -  35S-LABELED ( I h )  
FIG. 2 (left). EGF treatment stimulates EGF receptor syn- 
thesis. Cells were incubated for 4 h with [%]methionine with or 
without EGF. Immunoprecipitation with normal rabbit sera (nrs) 
(lane I )  or antisera 799 (lanes 2-61, 6% polyacrylamide  electropho- 
resis, and fluorography were performed as described under "Experi- 
mental Procedures." WB cells were exposed to  the following EGF 
concentrations  (ng/ml):  lanes I and 2,0; lane 3, 10; lane  4,30;  lane 5, 
100; and  lane 6, 300. The  arrow  denotes p170. 
FIG. 3 (right). Time course of EGF-induced EGF receptor 
synthesis. Confluent WB cells were incubated in 2% methionine- 
containing medium  for  4 h. EGF (10 ng/ml) was added  to  the cells 
for the  indicated  time (0 represents a  4-h incubation  without EGF); 
50 pCi of ["SS]methionine was present for the  last 1 h in all  samples. 
Immunoprecipitation was followed by 8% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and fluorography as described 
under  "Experimental Procedures." 
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TABLE I 
Time  and  dose  dependence of EGF-stimulated  EGF receptor  synthesis 
In  experiment A, cells  were incubated  with 2% methionine-containing medium and  EGF for 2 h. 50 FCi of [35Ss] 
methionine was then  added  to  each  plate  and  the  incubation  continued  for  another 2 h. After immunoprecipitation 
electrophoresis and fluorography, the p170 band was cut from dried gels and counted as described under 
“Experimental Procedures.” Duplicate  cultures were washed  and 0.5 ml of 10% trichloroacetic acid  was added. The 
trichloroacetic acid precipitates were scraped  and  the  plates were  washed with  an  additional 0.5 ml of trichloroacetic 
acid. The  samples were centrifuged  and  the  pellets were treated  with  NCS  Tissue Soluhilizer (Amersham Corp.) 
and  aliquots were counted.  In  experiment B,  cells  were incubated for 1-4 h in  the  presence of absence of 10 ng/ml 
EGF in 2% methionine-containing medium. During the last 1 h, 50 Ci [35S]methionine was added. Following 
immunoprecipitation,  the 35S-laheled p170 was quantitated  as above. 
Experiment A II Experiment B 
EGF [35S]Methionine p170 Control 
Time [3sS]Methionine 
p170 rated  ng/ml  EGF 
Control 
n,q/ml CPm % cpm X 
0 393 100 100 7.8 
3 737 188 113 8.8 
10 937  238 122 9.5 
30 1102 280 126 9.9 
100 885 225 121 9.4 
lo6 CPm % 
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FIG. 4. EGF treatment increases  cellular EGF receptor 
mRNA content. Total RNA was isolated from WB cells cultured 
for 4 h in  the  presence (lune 2 and 4 )  or absence (lane I and 3 )  of 100 
ng/ml  EGF. After electrophoresis  and  transfer  to nitrocellulose, hy- 
bridization was performed. In experiment 1 (lunes 1 and 2 )  cDNA 
probe 64-1, (ba  sequence  from  the coding  region of the  human  EGF 
receptor  extracellular  domain) was  used. In  experiment 2 (lanes 3 and 
4 )  cDNA 64-3, a sequence from the cytoplasmic coding region in 
pUC12 was  used. 
acetic acid precipitation  (10%) of duplicate  plates showed that 
3-30 ng/ml  EGF  increased  total 3sS incorporation by 13-26%. 
Gel slice counting of ‘”S-labeled  p170  showed a near  doubling 
of receptor  synthesis at 3 ng/ml  EGF  and a tripling at 30  ng/ 
ml EGF.  In  addition, cells were lysed in  electrophoresis  stop 
solution,  and  nuclear, cytosolic, and  particulate  fractions were 
subjected to polyacrylamide gel electrophoresis  and fluorog- 
raphy. No obvious increase  in  overall  protein  synthesis was 
observed after  treatment  with  EGF  (not  shown).  Lastly  EGF 
did not increase the labeling of other ”S-labeled proteins 
precipitated by normal  rabbit  serum  or  antiserum 799 (Figs. 
2 and 3). 
To  determine  whether  the  mechanism of EGF  action was 
pretranslational,  RNA was isolated (18) from  WB cells cul- 
tured for 4 h with  or  without 100 ng/ml  EGF. Fig. 4 shows 
Northern  blots of total  RNA  from  two  experiments.  Hybrid- 
ization was performed  with two cDNA  probes (21)  (generously 
provided by Axel Ullrich), 64-1, a sequence complementary  to 
a portion of the  external  domain of the  human  EGF receptor 
(lunes 1 and 2 )  and 64-3, a sequence complementary  to  the 
cytoplasmic domain (lunes 3 and 4 ) .  The  predominant  tran- 
script  in  WB cells was 9.5 kb,  slightly  smaller  than  the  largest 
transcript from human cells and tissues (21-23). The two 
lower molecular weight RNAs, more readily apparent on 
darker exposures, were 6.5 and 5.0 kb, again slightly different 
from  the  human  counterparts.  RNA  prepared  from  rat liver 
demonstrated  the  same 3 transcripts observed in  WB cells, 
again with a predominance of the 9.5-kb transcript. EGF 
(lunes 2 and 4 )  increased  receptor  mRNA  content  when  either 
cDNA  was  used for hybridization. Densitometry of autoradi- 
ographs revealed a 3-5-fold increase  in  the 9.5-kb transcript. 
Equal  amounts of RNA were transferred  from  the gel lanes 
as evidenced by equivalent hybridization of an 18 S RNA 
probe  (not  shown).  Preliminary  results show that injection of 
EGF  into  the  portal vein of a rat also resulted  in  an increase 
in  hepatic  EGF  receptor  mRNA  synthesis.3 
Until  the  recent  availability of antireceptor  antibodies  and 
cDNAs  complementary to receptor  mRNA,  analysis of recep- 
tor  synthesis  has been  difficult. This  has led to  an  emphasis 
on  the role of ligand in speeding internalization, a process 
that  rapidly  clears  the cell surface of 70-95% of its receptors. 
That some  functional  EGF  receptor  remains t   the  cell surface 
in  spite of saturating doses of EGF  is widely accepted,  because 
i t  is  known  that  extracellular  EGF  is necessary  for 6-8 h to 
trigger mitogenesis (24-26). This  might be due  in  part  to a 
class of receptors that  are immobile or uncoupled  from the 
down regulation process (27). Alternatively, EGF induction 
of EGF receptor synthesis could provide a supply of new 
surface receptor. This may explain the ability of EGF to 
continue a surface  signaling  function for 6-8  h. 
The data presented here clearly establish that receptor 
synthesis  is  not a constitutive process which responds only 
passively to down regulation. Rather,  receptor  synthesis  is a 
regulated process. The  literature  contains  examples of 
changes in EGF surface receptor number a t  different cell 
densities, during the cell cycle and following retinoic acid- 
induced differentiation (28-31). Since  the  receptor is an  in- 
ducible protein,  altered  receptor  synthesis may explain some 
of the  above-noted findings. In  fact, we have evidence that 
H. S. Earp, K. S. Austin, J. Blaisdell, M.-S. Tsao, L. W. Lee, and 
J. W. Grisham,  unpublished results. 
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density-dependent and retinoic acid-induced changes in he- 
patic epithelial cell EGF receptor number are due in part  to 
altered EGF receptor ~ynthesis.~ EGF has been previously 
demonstrated to stimulate transcription of several specific 
nucleic acid sequences (32, 33). The  EGF receptor appears to 
be yet another  transcript regulated by EGF, although defini- 
tive studies of nuclear transcription  rates  are needed, because 
changes in mRNA stability  are  not excluded by these experi- 
ments. 
Is this  a general phenomenon, homeostatic autoregulation 
of receptor mRNA synthesis by ligand action? With respect 
to  EGF, the phenomenon has also been observed in  human 
skin fibroblasts by Yarden and Ullrich.4 The answer remains 
to be determined for other ligand-receptor pairs, but ligand- 
directed increases in receptor number,  “up regulation,” have 
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